Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Explore by Poster Title
Home
Explore by Poster Title
Explore by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
A
30
A Medications for Addiction Treatment (MAT) Release Program in the CDOC
Favorite
52
Accelerated Inpatient Transition from Methadone to Long-Acting Injectable Buprenorphine
Favorite
2
Addressing the Whole Patient: Examination of Smoking Policies in SUD Treatment Facilities
Favorite
37
Administration and Prescribing of Medications for Alcohol Use Disorder During COVID-19
Favorite
109
An Atypical Case of Internet-Mediated Nootropic Use Disorder Involving Kratom and Phenibut
Favorite
9
AnyTime, AnyWhere: Examining Low-Barrier Buprenorphine for Post Incarcerated Individuals
Favorite
16
ASAM Criteria-based Standardized Recommendations and Discrepancies with Actual Referrals
Favorite
76
Association of Substance Use and Perinatal Mood and Anxiety Disorders in Pregnancy
Favorite
11
Associations between Gender and Prevalence of Daily Cannabis Use from 2008-2019
Favorite
69
Associations Between Umbilical Cord Drug Testing Results and PHQ-9 Scores (Pilot Study)
Favorite
87
Availability of Medications for Alcohol Use Disorder in Substance Use Treatment Facilities
Favorite
B
8
Breastfeeding in Postpartum Patients with Opioid Use Disorder
Favorite
97
Brief Assessment of Recovery Capital Linked to Treatment Completion Among Hispanics
Favorite
60
Buprenorphine Dose and Dosing Frequency Must Be Increased During Pregnancy
Favorite
112
Buprenorphine Microinduction in an Intubated and Sedated Patient
Favorite
C
90
Cannabis and Nicotine Use: Coping Mechanisms Among LGBTQIA+ College Students
Favorite
96
Caring for Patients Hospitalized with Injection-related Severe Bacterial Infections
Favorite
42
Characterization of Patient-Directed Discharge in Patients with Substance Use Disorder(s)
Favorite
15
Characterization of Young Adults Accessing Buprenorphine Telehealth in Philadelphia, PA
Favorite
70
Clinically Actionable Newborn Toxicology Results are Uncommon Under New Policy
Favorite
14
Comorbid Substance Use Disorders in Individuals with Diagnosed Eating Disorders
Favorite
61
Comparison of Opioid and Alcohol Use Disorders in an Urban Health System
Favorite
35
Consent First: Reviewing A Urine Drug Screening Protocol on Labor and Delivery
Favorite
13
Contraceptive Uptake in Postpartum People with and without Opioid Use Disorder
Favorite
D
62
Disparities in Identification and Treatment of Opioid Use Disorder in Primary Care
Favorite
102
Do Payment Modalities Incentivize Screening for Unhealthy Alcohol Use in Ambulatory Care?
Favorite
19
Dosing to effect with Subcutaneous and Sublingual Buprenorphine for Opioid Use Disorder
Favorite
E
22
Effect of Buprenorphine/Naloxone and Methadone on Methamphetamine/Amphetamine Use
Favorite
32
Enhancing Clinical Decision Support for Low-Threshold MAUD Prescribing in Primary Care
Favorite
63
Exploring the Relationship Between Coping and Relapse with People Who Use Opioids
Favorite
10
Exploring Unintended Pregnancy Among Patients with Opioid Use Disorder
Favorite
51
Extended-Release Injectable Buprenorphine For Same-Day Induction – A Case Series
Favorite
F
93
Factors Influencing Self-Help Group Attendance in Veterans with Substance Use Disorders
Favorite
91
Factors Predicting MOUD Access for (Un)housed Patients: A Machine Learning Approach
Favorite
59
False Positive PEth Testing and Implications in Liver Transplantation Selection Process.
Favorite
83
Fentanyl Test Strip Distribution Among Patients with Substance-Related ED Visits
Favorite
84
Fentanyl Test Strip Distribution in the Emergency Department: Early Experience and Outcomes
Favorite
55
Fentanyl to Buprenorphine < 24 Hours - Rapid Microinduction Buprenorphine Initiation
Favorite
'
47
''Gas Station Heroin'': Tianeptine, a Unique Tricyclic Antidepressant
Favorite
G
58
Getting Creative with Alpha Agonists: Xylazine Withdrawal in the Outpatient Setting
Favorite
38
Getting Well: Expanding Tools to Treat Opioid Use Disorder In the Hospital
Favorite
H
88
Harm Reduction among Cisgender Gay and Bisexual Men using Anabolic Androgenic Steroids
Favorite
111
Harm Reduction Street Outreach Clinical Services: A Case Study
Favorite
71
Healthcare Experiences of Pregnant Persons with Opioid Use Disorder: A Mixed-Methods Analysis
Favorite
54
High Dose Buprenorphine Induction Precipitating Non-Cardiogenic Pulmonary Edema
Favorite
64
Higher Substance and Opioid Use Disorder in Lean Patients with MASLD
Favorite
I
36
Impact of Addiction Consult Social Workers on Hospital Readmission Rates
Favorite
75
Impact of Opioid and Stimulant Co-Use on Perinatal Outcomes
Favorite
34
Impact of Telehealth on Visit Attendance for Women with Opioid Use Disorder
Favorite
43
Improving Linkage to Addiction Treatment with Extended-release Naltrexone
Favorite
31
Increasing Dual Nicotine Replacement Prescribing within a Large Integrated Health System
Favorite
101
Induction onto Buprenorphine Utilizing Transdermal Patches Over 24-48 Hours: IPPAS Method
Favorite
108
Infective Endocarditis in the Overdose Crisis: Addiction Care and Healthcare Utilization
Favorite
86
Inpatient Initiation of Long-Acting Injectable Buprenorphine: A Case Series
Favorite
12
Insurance and Racial/Ethnic Disparities in Receipt of Medications for Alcohol Use Disorder
Favorite
33
Integration of Long-acting Injectable PrEP with MAT: A Pre-implementation Study
Favorite
K
17
Keeping Patients in Care?: Factors Associated with Patients Returning to Care
Favorite
L
39
Linking Hospitalized People with OUD to Treatment: Findings from a Multisite RCT
Favorite
20
Low-Dose Buprenorphine Induction Protocols for Co-Occurring Pain and Opioid Use Disorders
Favorite
M
77
Maternal and Neonatal Outcomes in an Integrated Substance Use Disorder Treatment Program
Favorite
81
Methadone Take-Home Flexibilities and Mortality: Permitting vs. Non-Permitting States
Favorite
92
Military and Veteran Intensive Clinical Program with Alcohol and Substance Use Treatment
Favorite
5
Models for Accessing Harm Reduction Vending Machines: An Interrupted Time Series Design
Favorite
N
24
Naloxone Use and Knowledge from Patients Treated for Opioid Use Disorder
Favorite
78
Navigating Discrimination: Experiences of Pregnant Patients with Opioid Use Disorder
Favorite
28
Neurocognitive Disorder and Exposure to Medication for Opioid Use Disorder
Favorite
107
New Program Changes Utilization Patterns for Patients with Substance Use Disorders
Favorite
1
Nicotine Use and Patient Directed Discharge Rate in Psychiatric Inpatients
Favorite
44
Non-Clinical Barriers and Facilitators to Treatment for Youth Who Use Opioids
Favorite
56
Nonpharmacologic Interventions Ameliorate Withdrawal Signs in Opioid-Dependent Adults
Favorite
65
Nurse Practitioner Treatment of Opioid Use Disorder: A Phenomenographic Study
Favorite
O
48
Opportunities for Harm Reduction: Multi-domain Needs Assessment of Unhoused Individuals
Favorite
82
Organization of Primary Care and Early MOUD Discontinuation
Favorite
7
Outcomes of an Inpatient Microinduction Cross Taper Protocol, Results After 700+ Attempts
Favorite
26
Overdose after Medication for Opioid Use Disorder Initiation Following Hospitalization
Favorite
P
25
Patient Experiences with Telehealth Treatment for Opioid Use Disorder in Alabama
Favorite
85
Patient Perspectives on Hospital Initiation of Long-Acting Injectable Buprenorphine
Favorite
89
Perceived Risks of Psychedelics in Individuals with Substance Use and Psychiatric Disorders
Favorite
103
Perceptions of MOUD Among Peer Recovery Supporters: A Qualitative Study
Favorite
95
Perspectives from Hospitalized Patients with Substance Use Disorders: A Qualitative Study
Favorite
27
Pilot Study Comparing Traditional to Low-Dose Initiation with Buprenorphine
Favorite
40
Pilot Trial of a Digital Health Intervention for Opioid Use Disorder
Favorite
79
Postpartum Interpersonal Violence among Individuals with Opioid Use Disorder
Favorite
66
Predicting Fentanyl Use for Patients in Treatment for Opioid Use Disorder
Favorite
106
Primary Care Addiction Consultation Service: Colorado’s Implementation Support Project
Favorite
29
Prioritizing Integration of Prescription Drug Monitoring Program into the EHR
Favorite
80
PTSD Symptomatology Associated with Insomnia Severity Among Women Receiving Buprenorphine
Favorite
R
6
Racial Disparities in MOUD Initiation Among Medicaid Patients with Infective Endocarditis
Favorite
72
Racial Disparities in Substance Use Treatment and Perinatal Outcomes for Pregnant Women
Favorite
73
Racial Inequity in Newborn Drug Testing Despite Universal Prenatal Substance Use Screening
Favorite
46
Rapid Conversion of High Dose Methadone to Buprenorphine Due to Persistent Hypoglycemia
Favorite
53
Rapid Low-Dose – High-Dose Buprenorphine Initiation Using PO Methodology - Case Series
Favorite
110
Rapid Transition from High Dose Methadone to Long-Acting Injectable Buprenorphine
Favorite
50
Reduced Robo-Readmissions: Buprenorphine For Dextromethorphan Use Disorder
Favorite
S
67
Self-reported Tianeptine Experiences: A Mixed-Methods Study of Reddit Users
Favorite
104
Stakeholder Insights on Improving Care for Trauma Patients Who Use Methamphetamines
Favorite
21
State Office-based Buprenorphine Treatment Laws: Counseling, Dosage, and Visit Frequency
Favorite
57
Stuck in a Ketamine Use Cycle: Anxiety, Cystitis, and Pain
Favorite
3
Substance Use Treatment Utilization Among Community-Supervised Individuals at Risk for HIV
Favorite
T
94
The Evolution of Attitudes Towards Substance Use Disorder Throughout Medical Education
Favorite
23
The Impact of Mandatory Buprenorphine Training for Emergency Medicine Residents
Favorite
105
The Impact of Street Medicine and Mobile Clinics for Persons Experiencing Homelessness
Favorite
98
Tracking Cotinine: Screening for Tobacco Use in Hospitalized Pediatric Patients
Favorite
18
Transition from Sublingual to LA Injectable Buprenorphine Best Practices
Favorite
74
Treating Opioid Use Disorder in the Peripregnancy Period on Labor and Delivery
Favorite
114
Treatment of Poppy Seed Tea Dependence with Buprenorphine in a Telehealth Practice
Favorite
U
4
Unveiling Predictors and Impact: Harm Reduction Vending Machines in Clark County, NV
Favorite
45
Urine Drug Screening in a Telehealth Setting for Opioid Use Disorder Treatment
Favorite
113
Use of Diverted Buprenorphine before Starting Telehealth Opioid Use Disorder Treatment
Favorite
49
Using Interpretable Machine Learning to Predict Access to Buprenorphine in Pharmacies
Favorite
W
68
Which Should You Order? Blood vs. Urine Toxicology LC-QTOF-MS Testing
Favorite
X
41
Xylazine Test Strip Performance in Synthetic and Human Urine Biospecimens
Favorite
99
Xylazine Usage and Awareness among People who use Drugs in Denver, Colorado
Favorite
100
Xylazine Wound Care Among PWUD Accessing Massachusetts Syringe Service Programs
Favorite
